Recent Innovation & Upcoming Trends Myasthenia Gravis Treatment Market To 2030
December 26, 2022 ⚊ 1 Min read ⚊ Views 60 ⚊ BUSINESSThe myasthenia gravis treatment market size reached USD 1.24 Billion in 2021 and is expected to register a revenue CAGR of 7.5% during the forecast period. Global rise in prevalence of the disease is one of the main factors driving the myasthenia gravis treatment market revenue growth. For instance, the global prevalence of myasthenia gravis disease is estimated to be 12.4 individuals (95% CI 10.6-14.5) per 100,000 of the population. The number of myasthenia gravis patients is increasing, accounting more than doubled in the previous 20 years.
Tags: Myasthenia Gravis Treatment Market